Omega Therapeutics Inc

NASDAQ:OMGA  
5.03
+0.36 (+7.71%)
Earnings Announcements

Omega Therapeutics Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 11:54 GMT
Omega Therapeutics Inc (OMGA) - Omega Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress.
$173.7 Million in Cash, Cash Equivalents and Marketable Securities at End of Q2.
Net Loss for Q2 of 2022 Was $25.9 Million.
Qtrly Net Loss per Common Stock Attributable to Commonstockholders, Basic and Diluted $0.54.
Q2 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0.05 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.